Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable: A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 32902647.
- Also identified by DOI 10.1001/jamanetworkopen.2020.15083 and PMC identifier 7489808.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This secondary analysis of a randomized clinical trial examines the effect of androgen deprivation therapy (ADT) during radiotherapy in patients who were classified as having either favorable intermediate-risk or unfavorable intermediate-risk prostate cancer.
Medical subject headings
- Androgen Antagonists
- Long Term Adverse Effects
- Prostatic Neoplasms
- Radiotherapy